tiprankstipranks
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS

Apellis Pharmaceuticals (APLS) Similar Stocks

Compare
882 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Apellis Pharmaceuticals
$23.79
$2.98B
-58.69%
12 Buy
8 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$269.21
$36.55B
78.34%
18 Buy
4 Hold
0 Sell
Strong Buy
Neurocrine
$114.00
$11.41B
34.78
-19.24%
17 Buy
5 Hold
0 Sell
Strong Buy
Regeneron
$635.83
$69.98B
16.54
-33.93%
16 Buy
3 Hold
1 Sell
Strong Buy
Vertex Pharmaceuticals
$502.55
$128.47B
20.42%
15 Buy
10 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$71.81
$7.07B
30.58
-44.01%
17 Buy
2 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
APLS
Apellis Pharmaceuticals
24.28
-34.50
-58.69%
ALNY
Alnylam Pharma
271.02
121.57
81.34%
NBIX
Neurocrine
114.00
-23.92
-17.34%
REGN
Regeneron
635.83
-325.42
-33.85%
VRTX
Vertex Pharmaceuticals
502.55
84.54
20.22%
SRPT
Sarepta Therapeutics
71.81
-57.65
-44.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis